Phase 3b Study MT-1186-A02 of a Daily Dosing Regimen of Oral Edaravone Compared With the FDA-approved On/Off Regimen, Over 48 Weeks in Patients With Amyotrophic Lateral Sclerosis: An Update on a Pre-specified Futility Analysis
MUSCLE & NERVE（2023）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要